SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+43.6%
5Y CAGR+66.3%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
+43.6%/yr
Annual compound
5Y CAGR
+66.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
12.7x
Strong expansion
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
2025102.82+81.1%
202456.77+94.2%
202329.24-15.7%
202234.69-0.6%
202134.91+332.4%
20208.07-50.6%
201916.36-